The subject of the contract is the supply to the pharmacy of medicinal products, medical devices, biocidal products, cosmetics, raw materials for the recipe, small-molecule derivatives of heparin, foodstuffs for special purposes. A detailed description of the subject of the contract is contained in the model contract with an attachment (assortment – quantity – price specification), which is Annex 3 to the SWZ. Address of the website where changes and explanations of the content of the SWZ and other procurement documents directly related to the procurement procedure will be made available: hhttps://www.kcr.pl/zamowienia-publiczne-2021-2 - "website of the conducted procedure". A public contract is awarded in accordance with the Act of 11 September 2019 – Public Procurement Law in an unlimited tender procedure, using the so-called "reverse procedure" described in Article 139 of the Public Procurement Law.

Part 1/ Medicinal products of various therapeutic groups; A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 10/ Medicinal products of various therapeutic groups, raw materials for recipes, medical devices, special purpose foodstuffs. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 11/ Minor Molecular Heparin Derivatives. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 12/ Minor Molecular Heparin Derivatives. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 13/ Medicinal products of different therapeutic groups. A detailed description of the subject of the contract is contained in the model contract with an attachment (assortment – quantity – price specification), which is Annex 3 to the SWZ. The provisions of the SWZ should be read along with possible changes in the content of the SWZ, which are, for example, the result of answers to the Contractors' inquiries.

Part 14/ Medicinal products, medical devices, biocidal products. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 15/ Medicinal products, medical devices, biocidal products. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 16/ Medicinal products. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 17/ Medicinal products, medical devices, biocidal products. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 18/ Medicinal products of various therapeutic groups. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 19/ Medicinal products of various therapeutic groups. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 2/ Medicinal products of various therapeutic groups. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 20/ Medicinal products, medical devices, biocidal products and cosmetics. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 21/ Seams, including: task A - Non-absorbable seam - synthetic braided polyester coated with silicone; task B - bone wax,for hemostasis,when bleeding from bones in the form of flakes; task C - Absorbed sutures - braided made of a copolymer of 90% glycolide and 10% L-lactide coated with a copolymer and calcium stearate. Tissue support period after 14 days after implantation above 70% of the initial support strength, with a total suture absorption period of up to 70 days; task D - Absorbed sutures - Synthetic monofilament with a long absorption period (180 – 210 days) and a prolonged period of tissue support, after 28 days above 50 % of the initial tissue support force; task E - Absorbed seams - braided made of a copolymer of 90% glycolide and 10% L-lactide coated with copolymer and calcium stearate. Tissue support period 14 days after implantation above 70% of the initial support force, with a total suture absorption period of up to 70 days. Coated with antibacterial agent; task F - Non-absorbable seams - synthetic monofilament made of polypropylene and polyethylene. A detailed description of the subject of the contract is contained in the model contract with an attachment (assortment – quantity – price specification), which is Annex 3 to the SWZ. The provisions of the SWZ should be read along with possible changes in the content of the SWZ, which are, for example, the result of answers to the Contractors' inquiries.

Part 22/ Hemostatics. A detailed description of the subject of the contract is contained in the model contract with an attachment (assortment – quantity – price specification), which is Annex 3 to the SWZ. The provisions of the SWZ should be read along with possible changes in the content of the SWZ, which are, for example, the result of answers to the Contractors' inquiries.

Part 23/ Dressing materials. A detailed description of the subject of the contract is contained in the model contract with an attachment (assortment – quantity – price specification), which is Annex 3 to the SWZ. The provisions of the SWZ should be read along with possible changes in the content of the SWZ, which are, for example, the result of answers to the Contractors' inquiries.

Part 24/ Medicinal products of different therapeutic groups. A detailed description of the subject of the contract is contained in the model contract with an attachment (assortment – quantity – price specification), which is Annex 3 to the SWZ. The provisions of the SWZ should be read along with possible changes in the content of the SWZ, which are, for example, the result of answers to the Contractors' inquiries.

Part 25/ Medicinal products, medical devices, biocidal products and cosmetics. A detailed description of the subject of the contract is contained in the model contract with an attachment (assortment – quantity – price specification), which is Annex 3 to the SWZ. The provisions of the SWZ should be read along with possible changes in the content of the SWZ, which are, for example, the result of answers to the Contractors' inquiries.

Part 3/ Medicinal products of various therapeutic groups. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 4/ Medicinal products of various therapeutic groups. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 5/ Medicinal products, medical devices. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 6/ Medicinal products, medical devices. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 7/ Medicinal products of various therapeutic groups. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 8/ Minor Molecular Heparin Derivatives and Medicinal Products of Different Therapeutic Groups. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 9/ Medicinal products of various therapeutic groups. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.